New WHO classification of genetic variants causing G6PD deficiency
Authors:
Top Cited Papers
Open Access
- 1 August 2024
- journal article
- editorial
- Published by WHO Press in Bulletin of the World Health Organization
- Vol. 102 (08) , 615-617
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD GenotypeClinical Pharmacology & Therapeutics, 2022
- Genetic Variants of Glucose-6-Phosphate Dehydrogenase and Their Associated Enzyme Activity: A Systematic Review and Meta-AnalysisPathogens, 2022
- Glucose-6-phosphate dehydrogenase deficiencyBlood, 2020
- G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based MapPLOS Medicine, 2012
- Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group.1989
- Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia.Proceedings of the National Academy of Sciences, 1988
- Isolation of human glucose-6-pbosphate debydrogenase (G6PD) cDNA clones: primary structure of the protein and unusual 5' non-coding regionNucleic Acids Research, 1986
- Human glucose-6-phosphate dehydrogenase variants.1971
- Standardization of procedures for the study of glucose-6-phosphate dehydrogenase. Report of a WHO Scientific Group.1967
- Space-Time Relationships in Somesthetic LocalizationScience, 1956